PubMed · 8532029
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
F K Askari, W M McDonnell. 1996-02-01. Antisense-oligonucleotide therapy.. https://doi.org/10.1056/nejm199602013340508
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
Explore the source record for details and available documents.
SUMMARY: Type 2 diabetes represents the most common form of carbohydrate disorders affecting at least 5% of the population in the industrialized world. In addition to genetic predisposition obesity and a sedentary lifestyle are the main promoters. Recent data clearly suggest that lifestyle intervention in people at increased risk can potently reduce the incidence of the disease. In overt type 2 diabetes, good glycaemic control and aggressive management of associated cardiovascular risk factors may prevent its multiple and costly complications.